Literature DB >> 17280543

Laparoscopic adrenalectomy for the management of benign and malignant adrenal tumors.

Jamie Cyriac1, David Weizman, David R Urbach.   

Abstract

Laparoscopic adrenalectomy has become the preferred approach for removal of the adrenal gland. Many published studies support the use of laparoscopic adrenalectomy, with comparisons to open adrenalectomy suggesting many advantages to laparoscopy, including less postoperative pain, shorter hospital stay and earlier return to work. Adrenalectomy is usually required for the removal of adrenal tumors causing excess hormone production or because a malignant adrenal tumor cannot be excluded. Current controversies include the appropriateness of laparoscopic adrenalectomy for large or malignant tumors, the role of partial adrenalectomy and the management of some conditions with uncertain natural history (such as subclinical hypercortisolism). With the increased use of sensitive cross-sectional imaging, the detection of clinically inapparent adrenal masses is likely to continue to increase. Due to the fact that malignancy cannot be excluded with certainty in some patients with cortical adenomas, it is expected that the rate of laparoscopic adrenalectomy will continue to increase.

Entities:  

Mesh:

Year:  2006        PMID: 17280543     DOI: 10.1586/17434440.3.6.777

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  2 in total

1.  Trends in adrenal surgery: institutional review of 528 consecutive adrenalectomies.

Authors:  Anja Lachenmayer; Kenko Cupisti; Achim Wolf; Andreas Raffel; Matthias Schott; Holger S Willenberg; Claus F Eisenberger; Wolfram T Knoefel
Journal:  Langenbecks Arch Surg       Date:  2012-06-22       Impact factor: 3.445

2.  Laparoscopic adrenalectomy for a large pheochromocytoma in a morbidly obese patient.

Authors:  José Ignacio Rodríguez-Hermosa; Josep Roig-García; Jordi Gironès-Vilà; Bartomeu Ruiz-Feliú; Elisabet Costa-Lima; Mònica Recasens-Sala; Antoni Codina-Cazador
Journal:  Obes Surg       Date:  2008-10-23       Impact factor: 4.129

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.